Agitation Episode 3: Pharmacologic management of the agitated pediatric patient

Home
Resources
Clinical Resources (PEAKs)
Pediatric Education and Advocacy Kit (PEAK): Agitation
PEAK: Agitation Podcast Series
Agitation Episode 3: Pharmacologic management of the agitated pediatric patient

Agitation 3: Podcast

Episode 3 in a five-part series hosted by Brad Sobolewski (@PEMTweets) and co-authored by Dennis Ren (@DennisRenMD). This episode provides an overview of how medications should not always be the first option when managing an agitated pediatric patient and highlights how medications can be an adjunct to non-pharmacologic means to help keep agitated children safe from harm.

Agitation 3: Supplemental article

Article 3 in a five-part series authored by Dr. Manpreet Singh (@MprizzleER) from emdocs.net on age-appropriate pharmacologic management strategies for agitated children.

What care setting do you primarily work in?

EMS or fire-rescue agency

Emergency department

Trauma center

Other clinical setting

I do not work in a clinical setting

Which EMS agency or hospital do you currently work for? (May select up to three)

If your agency or hospital is not listed above, please specify

Please make sure you have searched for your agency or department's full, official name above before adding it.

Form version*

Requested resource

User action*

Uuid*

SIGN UP FOR UPDATES

Providing your details helps improve our free programs and resources. It also connects you with updates related to your role.

EIIC Mission

To optimize outcomes for children across the emergency care continuum by leveraging quality improvement science and multidisciplinary, multisystem collaboration. Learn more about our impact

About EIIC
Contact Us
Internal Site (password required)
Sign Up

Facebook
Twitter
Youtube
Linkedin
Instagram

The EMSC Innovation and Improvement Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U07MC37471) totaling $2.74M with 0 percent financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS or the U.S. government. For more information, visit HRSA.gov.